BIOAEGIS THERAPEUTICS, INC.

Profile

Company Names

BIOAEGIS THERAPEUTICS, INC.

Addresses

675 US HIGHWAY ONE, NORTH BRUNSWICK, NJ 08902

TECHNOLOGY CENTER OF NJ, 675 US HIGHWAY ONE, NORTH BRUNSWICK, NJ 08902

6 EAST COVE LANE, MORRISTOWN, NJ 07960

Phone Numbers

973-539-4552

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$42,390,297.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2021-12-23 
$21,770,592.00 
$21,770,592.00 
$0.00 
Equity 
4
2020-06-02 
$7,000,000.00 
$7,000,000.00 
$0.00 
Debt 
3
2018-08-01 
$4,083,293.00 
$7,000,000.00 
$2,916,707.00 
Equity 
2
2016-02-26 
$1,500,000.00 
$5,000,000.00 
$3,500,000.00 
Equity 
1
2012-03-30 
$8,036,412.00 
INDEFINITE 
INDEFINITE 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VALERIE 
 
CEVA 
EXECUTIVE OFFICER, DIRECTOR
STEVE 
 
CORDOVANO 
EXECUTIVE OFFICER
STEVEN 
 
CORDOVANO 
EXECUTIVE OFFICER
MARK 
 
DINUBILE 
EXECUTIVE OFFICER, DIRECTOR
SUSAN 
 
LEVINSON 
EXECUTIVE OFFICER, DIRECTOR
SUSAN 
L. 
LEVINSON 
EXECUTIVE OFFICER, DIRECTOR
JOHN 
 
STOSSEL 
DIRECTOR
THOMAS 
 
STOSSEL 
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-23 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-06-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-06-02 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-26 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-03-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#